Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma
暂无分享,去创建一个
A. Rajeswaran | T. Nielsen | M. Topp | M. Wenger | J. Duell | T. Wróbel | A. Guijarro | M. Odin | A. Bogucka-Fedorczuk | Christelle Zundel